Weaker And Weaker, Still

Look! … Squirrel!
While everyone else is focused on a ‘tradable bounce’ in the S&P, with others in a freak-out on gold, back at the ranch, biotech has continued to sub-divide lower, getting weaker and weaker, still.
Note: All trades presented on this site during 2024 (ex: UNG), and 2025, have been to the short side (not advice, not a recommendation).
Biotech XBI, Weekly
The chart highlights the Fibonacci retrace levels.

A Fibonacci 23.6%, retrace is rare; markets typically like to go to 38.2%, or 50%.
If this retrace holds, it indicates significant weakness in the sector (not advice, not a recommendation).
As can been seen in the side-bar, current biotech short is LABD-25-03, with stop at yesterday’s LABD, session low (not advice, not a recommendation).
Not shown on the chart, a trading channel that appears to be in-effect.
Update planned for that, later.
Stay Tuned
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279
















